Abstract
A general breakthrough in the prevention or therapy of neoplastic diseases is not likely to occur, before the potential of the “modern molecular biology” can be fully exploited. Whatever the prospects for such a major scenario change, the desired development will certainly require decades of basic and clinical research at many frontiers. Without a doubt, neoplastic disease will remain a major human and socioeconomic problem in the foreseeable future: one in three children born now are likely to suffer from life-threatening tumours during their lifetime.
Deceased. 12th October. 1998.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Larsson, B., Crompton, N.E.A. (2001). Monochromatic X-Rays, Slow Neutrons, and Radionuclides for Targeted Radiotherapy. In: Hawthorne, M.F., Shelly, K., Wiersema, R.J. (eds) Frontiers in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1285-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1285-1_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5478-9
Online ISBN: 978-1-4615-1285-1
eBook Packages: Springer Book Archive